Skip to main content
. Author manuscript; available in PMC: 2017 Apr 12.
Published in final edited form as: Pac Symp Biocomput. 2016;22:545–556. doi: 10.1142/9789813207813_0050

Table 3.

Population Demographics

Combined (n = 2181) Whites (n = 1928) Blacks (n = 253)
Weekly Warfarin Dose, mg/wk (median, sd) 35.0 (±17.6) 35.0 (±17.0) 40.8 (± 19.9)
Age, years (mean, sd) 66 (± 15) 66 (± 15) 60 (± 16)
Female (n, %) 911 (41.8%) 784 (40.7%) 127 (50.2%)
African American (n, %) 253 (11.6%) - -
% African Ancestry (median, sd)1 0.99 (± 31) 0.65 (± 4.5) 81.6 (± 10.3)
Height, cm (median, sd) 173 (± 13.5) 174 (±13.0) 170 (±16.1)
Weight, kg (median, sd) 89 (± 24.0) 88 (± 23.9) 91 (±24.7)
Body Surface Area, m2 (median, sd) 2.0 (± 0.29) 2.0 (± 0.29) 2.0 (± 0.30)
Current Smokers (n, %) 209 (9.6%) 168 (8.7%) 41 (16.2%)
Amiodarone (n, %) 229 (10.5%) 202 (10.5%) 27 (10.7%)
Enzyme Inducers (n, %) 20 (0.92%) 15 (0.78%) 5 (1.98%)
Indication
 VTE (n, %) 414 (19.0%) 337 (17.5%) 77 (30.4%)
 Atrial Fibrillation (n, %) 1592 (73%) 1443 (75%) 149 (59%)
1

%-African ancestry available for 987 individuals (808 whites, 179 blacks)